Skip links

Antidiabetics

ENG -_0011_antidiabeticos

Therapeutic Antidiabetic Line

The prevalence of diabetes keeps rising around the entire world, in Mexico, there are 6.4 million diabetics, of which only 25% follows an adequate control of their glucose levels, nowadays it is known that only 80% of diabetes cases are related to weight problems and obesity and that it is the main cause of death in our country in people over 45 years old.

Fazique® | Sitagliptin

It’s indicated as a complement to diet and exercise to improve glycemic level control in patients with Type II Diabetes.

Presentations

  • Box with 28 100 mg tablets
  • Box with 14 100 m tablets
Check IPP

Glitacar® | Pioglitazone

To improve the glycemic level control in patients with Type II Diabetes (non-insulin-dependent diabetes mellitus, NIDDM); indicated as monotherapy or combined therapy along with insulin or any oral hypoglycemic agents: sulfonylurea, metformin, DDP-4 inhibitors, SGLT-2 inhibitors, GLP-1 agonist, alpha glucosidase inhibitors, when diet and exercise combined with the sole agent doesn’t yield good results in the adequate control  of glycemia.

Presentations

  • Box with seven 15 mg tablets
  • Box with thirty 15 mg tablets
  • Box with seven 30 mg tablets
  • Box with thirty 30 tablets
Check IPP

Velmetia® | Sitagliptin/Metformin

It’s indicated as initial treatment in patients with type II diabetes for the control of glycemia when diet and exercise don’t provide an adequate control.

Presentations

  • Box with 56 850mg/50mg tablets
  • Box with 28 850mg/50mg tablets
  • Box with 56 500mg/50mg tablets
  • Box with 28 500 mg/50 mg tablets
Check IPP

Prescription Products

Dental
Pain Killers
Cardiovascular Medication
Antiparasitic Medication
Anti-warts
Erectile Disfunction
Antidiabetics
Contraceptives
Antivirals
Antiobesity
Antihistamines
Bone Calcium Regulation
Gastrointestinal
Overactive Bladder
Anti-infectious
Neuromodulators
Supplements
Respiratory Medications
Return to top of page